Headlines

Abbott Laboratories (ABT) Q2 2026 (USD): Adj. EPS 1.31 (exp. 1.28), Revenue 12.6bln (exp. 12.52bln). Raises FY adj. EPS view 5.45-5.60 (exp. 5.49, prev. 5.38-5.58), Reaffirms sales growth view 6.5-7.5%.

Newsquawk Staff ·

Abbott Laboratories (ABT) Q2 2026 (USD): Adj. EPS 1.31 (exp. 1.28), Revenue 12.6bln (exp. 12.52bln). Raises FY adj. EPS view 5.45-5.60 (exp. 5.49, prev. 5.38-5.58), Reaffirms sales growth view 6.5-7.5%.

Related headlines